Djp Unipolar
Biotronik Sales
FDA Clearance Information
The DJP Unipolar, manufactured by Biotronik Sales, was cleared through the FDA 510(k) pathway on May 7, 1986. It is classified as a Class III device under product code DTB.
What It Is
FDA-Cleared Indications
- Cardiac pacing for patients with bradycardia or other rhythm disorders requiring electrical stimulation.
- Use in patients who require cardiac pacing to maintain an adequate heart rate.
Clinical Applications
- Pacing support for symptomatic bradycardia.
- Cardiac pacing for selected heart rhythm disorders requiring electrical stimulation.
- Implantation with a compatible pacing lead in a hospital electrophysiology or cardiology setting.
- Long-term pacing support when determined appropriate by a cardiologist or electrophysiologist.
Practical Considerations
- The device is associated with unipolar cardiac pacing and must be used with a compatible pacing lead and pacing system.
- Implantation requires careful positioning, connection, testing and follow-up by trained cardiac specialists.
- The available record does not provide specific device dimensions, lead compatibility details or MRI-conditional labeling.
- MRI safety should not be assumed; clinicians should verify the complete implanted system and current manufacturer or FDA labeling before MRI.
- Contraindications, precautions and expected service life depend on the complete pacing system, patient condition and current product labeling.
Frequently Asked Questions
What is DJP Unipolar used for?
The DJP Unipolar is used to manage heart rhythm disorders, particularly in patients with bradycardia, by providing electrical pacing to the heart.
What specialties typically use this device?
Cardiologists and electrophysiologists typically use the DJP Unipolar in interventional cardiology and electrophysiology settings.
What are the FDA-cleared indications?
The device is indicated for patients with conditions like bradycardia, where it helps maintain an adequate heart rate through electrical stimulation.